GAMMA BIOSCIENCES BIDCO LIMITED

12303230
Active London

Activities of other holding companies n.e.c.

0 employees website.com
Activities of other holding companies n.e.c.
G

GAMMA BIOSCIENCES BIDCO LIMITED

12303230

Activities of other holding companies n.e.c.

Founded 7 Nov 2019 Active London, United Kingdom 0 employees website.com
Activities of other holding companies n.e.c.
Accounts Submitted 3 Dec 2025 Next due 30 Sept 2026 2 months remaining
Confirmation Submitted 24 Dec 2025 Next due 20 Nov 2026 4 months remaining
Net assets £143M £4M 2024 year on year
Total assets £172M £6M 2024 year on year
Total Liabilities £29M £2M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Duo, Level 6 280 Bishopsgate London EC2M 4RB United Kingdom

Full company profile for GAMMA BIOSCIENCES BIDCO LIMITED (12303230), an active company based in London, United Kingdom. Incorporated 7 Nov 2019. Activities of other holding companies n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 2 months remaining

Balance Sheet & P&L (2020–2024)

Cash in Bank

£2.70M

Increased by £1.79M (+197%)

Net Assets

£143.16M

Increased by £3.72M (+3%)

Total Liabilities

£29.34M

Increased by £1.84M (+7%)

Turnover

£15.93M

Decreased by £169.45M (-91%)

Employees

N/A

Debt Ratio

17%

Increased by 1 (+6%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 32,625,997 Shares £32.63m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
31 May 20234$0$0
29 Sept 20208,504,710$8.50m$1
8 Jul 202024,121,283$24.12m$1

Officers

Officers

1 active 2 resigned
Status
Anogie Joseph-eramehDirectorBritishUnited Kingdom367 Jul 2020Active

Shareholders

Shareholders (1)

Gamma Biosciences L.p
100.0%
78,595,347

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Kkr & Co. Inc.

United States Of America

Active
Notified 17 Apr 2023
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

GAMMA BIOSCIENCES BIDCO LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 Dec 2025OfficersChange to director Anogie Joseph-Erameh on 5 May 2025
24 Dec 2025Confirmation StatementConfirmation statement made on 6 Nov 2025 with updates
22 Dec 2025OfficersAppointment of Anogie Joseph-Erameh as director
3 Dec 2025AccountsAnnual accounts made up to 31 Dec 2024
18 Nov 2025OfficersChange to director Mr. Anogie Joseph-Erameh on 18 Nov 2025
27 Dec 2025 Officers

Change to director Anogie Joseph-Erameh on 5 May 2025

24 Dec 2025 Confirmation Statement

Confirmation statement made on 6 Nov 2025 with updates

22 Dec 2025 Officers

Appointment of Anogie Joseph-Erameh as director

3 Dec 2025 Accounts

Annual accounts made up to 31 Dec 2024

18 Nov 2025 Officers

Change to director Mr. Anogie Joseph-Erameh on 18 Nov 2025

Recent Activity

Latest Activity

Change to director Anogie Joseph-Erameh on 5 May 2025

6 months ago on 27 Dec 2025

Confirmation statement made on 6 Nov 2025 with updates

6 months ago on 24 Dec 2025

Appointment of Anogie Joseph-Erameh as director

6 months ago on 22 Dec 2025

Annual accounts made up to 31 Dec 2024

7 months ago on 3 Dec 2025

Change to director Mr. Anogie Joseph-Erameh on 18 Nov 2025

7 months ago on 18 Nov 2025